Breaking News Instant updates and real-time market news.

MIME

Mimecast

$19.28

0.15 (0.78%)

13:24
10/04/16
10/04
13:24
10/04/16
13:24

Index Ventures reports 8.85% passive stake in Mimecast

  • 14

    Nov

MIME Mimecast
$19.28

0.15 (0.78%)

04/15/16
GSCO
04/15/16
DOWNGRADE
Target $10.5
GSCO
Neutral
Mimecast downgraded to Neutral from Buy at Goldman
Goldman Sachs analyst Heather Bellini downgraded Mimecast to Neutral citing increasing competitive pressure from "large email incumbents." The analyst says the risk/reward has become less favorable. She cut her price target for the shares to $10.50 from $12.
05/17/16
JEFF
05/17/16
NO CHANGE
Target $18
JEFF
Buy
Mimecast business momentum accelerating, says Jefferies
Jefferies analyst John DiFucci says Mimecast's Q1 results show the company's business momentum is accelerating. The company easily exceeded all metrics for Q4, the analyst tells investors in a post-earnings research note. DiFucci views the current valuation as compelling and keeps a Buy rating on Mimecast with an $18 price target.
05/24/16
OPCO
05/24/16
NO CHANGE
Target $15
OPCO
Outperform
Mimecast product line may disrupt legacy solutions, says Oppenheimer
Oppenheimer analyst Shaul Eyal believes Mimecast's product line has the potential to disrupt legacy solutions as IT decision makers look for scalable and easy-to-install subscription services. The analyst sees the stock current valuation as a "compelling" opportunity for investors. Eyal reiterates an Outperform rating and $15 price target on the shares.
09/01/16
OPCO
09/01/16
NO CHANGE
Target $20
OPCO
Outperform
Mimecast price target raised to $20 from $15 at Oppenheimer
Oppenheimer analyst Shaul Eyal raised his price target to $20 from $15 based on his increasing confidence in the company's long-term prospects. The analyst believes Mimecast's "strong" June-quarter performance demonstrated the underlying strength of its model. Furthermore, he sees the company's multi-tenancy platform as a competitive differentiator that will enable it to accelerate revenue growth and expand EBITDA margins. Eyal reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

AMD

AMD

$13.74

0.62 (4.73%)

, NVDA

Nvidia

$185.84

-1.51 (-0.81%)

08:05
09/21/17
09/21
08:05
09/21/17
08:05
Recommendations
AMD, Nvidia, Tesla analyst commentary  »

Tesla shift to AMD from…

AMD

AMD

$13.74

0.62 (4.73%)

NVDA

Nvidia

$185.84

-1.51 (-0.81%)

TSLA

Tesla

$373.91

-1.19 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

ALNY

Alnylam

$113.84

38.8 (51.71%)

08:05
09/21/17
09/21
08:05
09/21/17
08:05
Recommendations
Alnylam analyst commentary  »

Alnylam data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:05
09/21/17
09/21
08:05
09/21/17
08:05
General news
Canada wholesale trade report preview »

Canada wholesale trade…

BHGE

Baker Hughes

$37.50

0.11 (0.29%)

08:04
09/21/17
09/21
08:04
09/21/17
08:04
Recommendations
Baker Hughes analyst commentary  »

Baker Hughes 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 20

    Oct

SCG

Scana

$57.80

-0.41 (-0.70%)

08:04
09/21/17
09/21
08:04
09/21/17
08:04
Hot Stocks
Scana receives subpoena for documents relating to nuclear project »

Scana announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TANH

Tantech Holdings

$4.07

0.08 (2.01%)

08:03
09/21/17
09/21
08:03
09/21/17
08:03
Hot Stocks
Tantech Holdings awarded $20M in electric van and bus sales orders »

Tantech Holdings'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VR

Validus

$46.93

1.2 (2.62%)

08:03
09/21/17
09/21
08:03
09/21/17
08:03
Recommendations
Validus analyst commentary  »

Validus net exposure to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOLD

Audentes Therapeutics

$26.57

1.04 (4.07%)

08:02
09/21/17
09/21
08:02
09/21/17
08:02
Hot Stocks
Audentes Therapeutics doses first patient in ASPIRO trial »

Audentes Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELGX

Endologix

$4.29

-0.15 (-3.38%)

08:01
09/21/17
09/21
08:01
09/21/17
08:01
Hot Stocks
Endologix announces CE Mark approval for Nellix system »

Endologix announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$156.07

-2.66 (-1.68%)

08:00
09/21/17
09/21
08:00
09/21/17
08:00
Options
Apple call buyer realizes 32% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

08:00
09/21/17
09/21
08:00
09/21/17
08:00
General news
Treasury Market Outlook: bonds remain mostly weaker »

Treasury Market Outlook:…

NVDA

Nvidia

, TSLA

Tesla

07:58
09/21/17
09/21
07:58
09/21/17
07:58
Technical Analysis
Technical View: AMD trades up on report it is working with Tesla on AI chip »

In the pre-market the AMD…

NVDA

Nvidia

TSLA

Tesla

AMD

AMD

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

JAKK

JAKKS Pacific

$3.15

0.325 (11.50%)

07:56
09/21/17
09/21
07:56
09/21/17
07:56
Downgrade
JAKKS Pacific rating change  »

JAKKS Pacific downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCL

Royal Caribbean

$114.94

-2.98 (-2.53%)

07:56
09/21/17
09/21
07:56
09/21/17
07:56
Conference/Events
Royal Caribbean management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RMBS

Rambus

$13.35

-0.23 (-1.69%)

07:55
09/21/17
09/21
07:55
09/21/17
07:55
Conference/Events
Rambus to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Oct

MO

Altria Group

$61.22

-1.01 (-1.62%)

07:54
09/21/17
09/21
07:54
09/21/17
07:54
Recommendations
Altria Group analyst commentary  »

Altria cigarette price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCO

Moody's

$136.77

0.03 (0.02%)

07:50
09/21/17
09/21
07:50
09/21/17
07:50
Conference/Events
Moody's management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

LII

Lennox

$170.37

4.54 (2.74%)

07:49
09/21/17
09/21
07:49
09/21/17
07:49
Conference/Events
Lennox management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 26

    Sep

APRN

Blue Apron

$5.22

-0.29 (-5.26%)

07:49
09/21/17
09/21
07:49
09/21/17
07:49
Technical Analysis
Technical View: Blue Apron trades highe as Plated acquired by Albertsons »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIVI

II-VI

07:48
09/21/17
09/21
07:48
09/21/17
07:48
Conference/Events
II-VI management to meet with B. Riley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 28

    Sep

  • 13

    Nov

HSC

Harsco

$19.70

-0.2 (-1.01%)

07:47
09/21/17
09/21
07:47
09/21/17
07:47
Conference/Events
Harsco management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

TXN

Texas Instruments

$85.83

-0.98 (-1.13%)

07:44
09/21/17
09/21
07:44
09/21/17
07:44
Recommendations
Texas Instruments analyst commentary  »

Texas Instruments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$438.17

6.79 (1.57%)

, AMGN

Amgen

$188.17

1.85 (0.99%)

07:44
09/21/17
09/21
07:44
09/21/17
07:44
Recommendations
Regeneron, Amgen, AstraZeneca, AbbVie analyst commentary  »

Regeneron price target…

REGN

Regeneron

$438.17

6.79 (1.57%)

AMGN

Amgen

$188.17

1.85 (0.99%)

AZN

AstraZeneca

$32.93

0.26 (0.80%)

ABBV

AbbVie

$87.41

1.04 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 25

    Sep

  • 27

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

ALNY

Alnylam

$113.84

38.8 (51.71%)

07:44
09/21/17
09/21
07:44
09/21/17
07:44
Recommendations
Alnylam analyst commentary  »

Alnylam price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHF

Brighthouse Financial

$57.49

0.56 (0.98%)

07:43
09/21/17
09/21
07:43
09/21/17
07:43
Initiation
Brighthouse Financial initiated  »

Brighthouse Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.